Literature DB >> 29454409

Inhibition of NLRP1 inflammasome might be a novel therapeutic target in the treatment of peripheral arterial disease.

Wei Wang1, Chunsong Wang2, Ying Gong2, Xin Zhang2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29454409     DOI： 10.1016/j.ijcard.2017.10.125

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  2 in total

Review 1.  Emerging Roles of Inflammasomes in Cardiovascular Diseases.

Authors:  Yingnan Liao; Kui Liu; Liyuan Zhu
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

2.  Predictive role of endothelial cell activation in cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukaemia.

Authors:  Fei Hong; Ming Shi; Jiang Cao; Ying Wang; Yanqing Gong; Hui Gao; Zhenyu Li; Junnian Zheng; Lingyu Zeng; Aili He; Kailin Xu
Journal:  J Cell Mol Med       Date:  2021-11-03       Impact factor: 5.310
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.